Kopran FY26 Net Profit Rises; Board Declares Dividend

2 min read     Updated on 22 May 2026, 03:13 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Kopran Ltd reported a consolidated net profit of ₹2,573.12 lakh for FY26, with Q4 net profit rising to ₹1,887 lakh. Revenue for the year grew to ₹68,142.36 lakh. The Board recommended a ₹3.00 per share dividend and appointed Mrs. Namrata Somani as an Additional Director.

powered bylight_fuzz_icon
40738741

*this image is generated using AI for illustrative purposes only.

Kopran Ltd has announced its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board of Directors, which met on May 19, 2026, approved the financial statements, recommended a dividend for the fiscal year, and made a key board appointment. Additionally, the company filed an investor presentation with the exchanges on May 20, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Q4 Performance Highlights

Kopran delivered a strong quarterly performance, with consolidated net profit for Q4 rising to ₹1,887 lakh compared to ₹968 lakh in the same quarter of the prior year. Revenue from operations for the quarter grew to ₹23,402 lakh from ₹17,236 lakh in the corresponding prior-year period. EBITDA for Q4 improved significantly to ₹4,057 lakh versus ₹1,400 lakh in Q4 of the prior year, with the EBITDA margin expanding to 17.34% from 8.12% year-on-year, indicating improved operational efficiency. The company achieved its highest ever quarterly revenue and EBITDA during this period.

The following table presents the key Q4 year-on-year comparisons on a consolidated basis:

Metric: Q4 FY26 Q4 FY25 (YoY)
Net Profit: ₹1,887 lakh ₹968 lakh
Revenue from Operations: ₹23,402 lakh ₹17,236 lakh
EBITDA: ₹4,057 lakh ₹1,400 lakh
EBITDA Margin: 17.34% 8.12%

Full-Year Financial Performance

For the financial year ended March 31, 2026, the company reported a consolidated net profit of ₹2,573.12 lakh, compared to ₹3,855.19 lakh in the previous year. Revenue from operations for the year increased to ₹68,142.36 lakh from ₹62,960.44 lakh in FY25. On a standalone basis, the net profit for the year was ₹3,039.97 lakh, up from ₹2,685.62 lakh in the prior year, while standalone revenue from operations rose to ₹30,564.62 lakh from ₹27,100.95 lakh in the previous year.

The following table summarizes the key financial figures for the consolidated and standalone results for the year ended March 31, 2026:

Particulars: Consolidated (₹ in Lakhs) Standalone (₹ in Lakhs)
Revenue from Operations: 68,142.36 30,564.62
Total Income: 68,176.93 30,764.51
Total Expenses: 64,741.31 26,725.12
Net Profit for the Year: 2,573.12 3,039.97
Basic EPS (₹): 5.33 6.30

Dividend Declaration

The Board has recommended a dividend of ₹3.00 per equity share, representing 30% of the face value of ₹10 each. This dividend is subject to the approval of the shareholders at the forthcoming 67th Annual General Meeting.

Board Appointment

During the meeting, the Board appointed Mrs. Namrata Somani as an Additional Director (Non-Executive, Promoter Group) effective May 19, 2026. Her appointment is subject to shareholder approval and she is liable to retire by rotation.

Historical Stock Returns for Kopran

1 Day5 Days1 Month6 Months1 Year5 Years
-2.43%+3.32%+6.84%+26.88%-15.07%-14.68%

Can Kopran sustain its record-breaking Q4 EBITDA margins of 17.34% into FY27, or were there one-time factors driving the exceptional quarterly performance?

How might Mrs. Namrata Somani's appointment as a Promoter Group director influence Kopran's strategic direction and capital allocation decisions going forward?

Given that full-year consolidated net profit declined despite revenue growth, what restructuring or cost optimization measures is Kopran likely to pursue to improve annual profitability in FY27?

Kopran's Subsidiary Appoints Chandresh Gandhi as Independent Director, Announces Rights Issue to Raise Rs.18.75 Cr

2 min read     Updated on 19 May 2026, 05:13 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Kopran Research Laboratories Limited (KRLL), a subsidiary of Kopran Limited, approved the appointment of Mr. Chandresh Gunvant Gandhi (DIN: 00707947) as Additional Independent Director for a five-year term from May 18, 2026 to May 17, 2031, subject to shareholder approval. The Board also approved a rights issue in the ratio of 1 share for every 12 held at a face value of 10/- and a premium of Rs.90/- per share, aiming to raise Rs.18.75 Cr for working capital requirements.

powered bylight_fuzz_icon
40693346

*this image is generated using AI for illustrative purposes only.

Kopran Research Laboratories Limited (KRLL), a subsidiary of Kopran Limited, convened a Board of Directors meeting on May 18, 2026, and approved two significant corporate actions — the appointment of an Additional Independent Director and a rights issue to meet working capital needs. The disclosure was made pursuant to Regulation 30(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Appointment of Additional Independent Director

The Board of KRLL, based on the recommendation of its Nomination and Remuneration Committee, approved the appointment of Mr. Chandresh Gunvant Gandhi as Additional Director in the Non-Executive, Independent Category. Mr. Gandhi, who also serves as an Independent Director of Kopran Limited, has been appointed for a first term of five consecutive years, subject to approval by the members of the company at the Annual General Meeting.

Key details of the appointment are summarised below:

Parameter: Details
Name: Mr. Chandresh Gunvant Gandhi
DIN: 00707947
Designation: Additional Director (Non-Executive, Independent Category)
Term: First term of 5 consecutive years
Appointment Date: May 18, 2026
Tenure End Date: May 17, 2031
Subject To: Approval of shareholders at Annual General Meeting
Relationship with Other Directors: None
Debarment Status: Not debarred from holding office of director by any SEBI order or any such authority

Profile of Mr. Chandresh Gunvant Gandhi

Mr. Chandresh Gunvant Gandhi is a Chartered Accountant with more than 30 years of professional practice. He is the Managing Partner of M/s Dosi and Jain, a Chartered Accountant firm. His professional experience spans a broad range of audit, advisory, and taxation engagements, including:

  • Concurrent Auditor of a leading foreign bank for more than two decades, covering All India Inward and Outward remittances — FTU unit and Imports/Exports Trade Unit as per Reserve Bank of India guidelines
  • Internal Auditor for a leading commodity exchange in India for almost 10 years
  • Statutory Auditor of a listed company for more than 20 years
  • Conducted Statutory audit of nationalised bank branches allotted on the basis of empanelment
  • Provided advisory services and representation before authorities in Auditing and Accounting, Local and International Taxation, including interpretation of Tax Treaties, Transfer Pricing, and FEMA issues relating to Inbound and Outbound Investments under RBI guidelines for NRIs, local corporates, and foreign companies
  • Advised on cross-border transactions involving structuring from a taxation point of view under the Double Taxation Avoidance Agreement (DTAA) with various countries, and represented before tax authorities in assessments, appeals, and compounding matters with the RBI

Rights Issue to Fund Working Capital

In addition to the directorial appointment, the KRLL Board also approved the issuance of rights shares to raise funds for working capital requirements. The key terms of the rights issue are outlined below:

Parameter: Details
Issue Type: Rights Issue
Ratio: 1 share for every 12 held
Face Value: 10/-
Premium: Rs.90/- per share
Purpose: Working capital requirement
Amount to be Raised: 18.75 Cr

The disclosure was signed by Sunil Sodhani, Company Secretary & Compliance Officer of Kopran Limited (Membership No. FCS 3897), and filed with both BSE Limited and the National Stock Exchange of India Limited in accordance with applicable regulatory requirements.

Historical Stock Returns for Kopran

1 Day5 Days1 Month6 Months1 Year5 Years
-2.43%+3.32%+6.84%+26.88%-15.07%-14.68%

How will the ₹18.75 crore raised through the rights issue be deployed, and what specific working capital gaps or expansion plans does KRLL aim to address in the near term?

Given that Mr. Chandresh Gandhi serves as Independent Director on both Kopran Limited and KRLL simultaneously, how might this dual role influence governance dynamics and potential conflicts of interest between the parent and subsidiary?

Could the rights issue at a 1:12 ratio signal further capital-raising rounds ahead, and how might existing minority shareholders respond to potential equity dilution?

More News on Kopran

1 Year Returns:-15.07%